Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker
- PMID: 14707317
- PMCID: PMC1757481
Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker
Abstract
Objective: We performed (1)H-MR spectroscopy ((1)H-MRS) on multiple brain regions to determine the metabolite pattern and diagnostic utility of (1)H-MRS in multiple system atrophy (MSA).
Methods: Examining single voxels at 3.0 T, we studied metabolic findings of the putamen, pontine base, and cerebral white matter in 24 MSA patients (predominant cerebellar ataxia (MSA-C), n = 13), parkinsonism (MSA-P), n = 11), in 11 age and duration matched Parkinson's disease patients (PD) and in 18 age matched control subjects.
Results: The N-acetylaspartate to creatine ratio (NAA/Cr) in MSA patients showed a significant reduction in the pontine base (p<0.0001) and putamen (p = 0.02) compared with controls. NAA/Cr in cerebral white matter also tended to decline in long standing cases. NAA/Cr reduction in the pontine base was prominent in both MSA-P (p<0.0001) and MSA-C (p<0.0001), and putaminal NAA/Cr reduction was significant in MSA-P (p = 0.009). It was also significant in patients who were in an early phase of their disease, and in those who showed no ataxic symptoms or parkinsonism, or did not show any MRI abnormality of the "hot cross bun" sign or hyperintense putaminal rims. NAA/Cr in MSA-P patients was significantly reduced in the pontine base (p = 0.001) and putamen (p = 0.002) compared with PD patients. The combined (1)H-MRS in the putamen and pontine base served to distinguish patients with MSA-P from PD more clearly.
Conclusions: (1)H-MRS showed widespread neuronal and axonal involvement in MSA. The NAA/Cr reduction in the pontine base proved highly informative in the early diagnosis of MSA prior to MRI changes and even before any clinical manifestation of symptoms.
Similar articles
-
The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease?Acta Radiol. 2015 Mar;56(3):322-8. doi: 10.1177/0284185114524090. Epub 2014 Mar 11. Acta Radiol. 2015. PMID: 24619850
-
The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes.Parkinsonism Relat Disord. 2015 Aug;21(8):929-37. doi: 10.1016/j.parkreldis.2015.05.025. Epub 2015 Jun 3. Parkinsonism Relat Disord. 2015. PMID: 26077167
-
[Magnetic resonance spectroscopy in Parkinson's disease and multiple system atrophy].Nihon Rinsho. 1997 Jan;55(1):249-54. Nihon Rinsho. 1997. PMID: 9014459 Review. Japanese.
-
Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.Eur J Neurol. 2010 Sep;17(9):1193-1202. doi: 10.1111/j.1468-1331.2010.03010.x. Epub 2010 Apr 14. Eur J Neurol. 2010. PMID: 20402762
-
Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients.Brain. 2002 May;125(Pt 5):1070-83. doi: 10.1093/brain/awf117. Brain. 2002. PMID: 11960896 Review.
Cited by
-
Biomarkers of Bipolar Disorder in Late Life: An Evidence-Based Systematic Review.Curr Psychiatry Rep. 2024 Mar 12. doi: 10.1007/s11920-024-01483-7. Online ahead of print. Curr Psychiatry Rep. 2024. PMID: 38470559 Review.
-
Nutritional Status and Metabolism in Celiac Disease: Narrative Review.J Clin Med. 2023 Aug 3;12(15):5107. doi: 10.3390/jcm12155107. J Clin Med. 2023. PMID: 37568509 Free PMC article. Review.
-
Accelerated Repetitive Transcranial Magnetic Stimulation to Treat Major Depression: The Past, Present, and Future.Harv Rev Psychiatry. 2023 May-Jun 01;31(3):142-161. doi: 10.1097/HRP.0000000000000364. Harv Rev Psychiatry. 2023. PMID: 37171474 Free PMC article.
-
Differentiation of Parkinson's disease and Parkinsonism predominant multiple system atrophy in early stage by morphometrics in susceptibility weighted imaging.Front Hum Neurosci. 2022 Aug 2;16:806122. doi: 10.3389/fnhum.2022.806122. eCollection 2022. Front Hum Neurosci. 2022. PMID: 35982687 Free PMC article.
-
Proton Magnetic Resonance Spectroscopy for the Early Diagnosis of Parkinson Disease in the Substantia Nigra and Globus Pallidus: A Meta-Analysis With Trial Sequential Analysis.Front Neurol. 2022 Jun 16;13:838230. doi: 10.3389/fneur.2022.838230. eCollection 2022. Front Neurol. 2022. PMID: 35785357 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical